MMPathIC: Engaging Engineers and Physical Scientists - Funding Available
The Manchester Molecular Pathology Innovation Centre (MMPathIC) is co-funded by the Engineering and Physical Sciences Research Council, as both EPSRC and the MRC recognise the key role that the EPS disciplines will need to play to develop the next generation of diagnostics and molecular pathology tests. To kick start this necessary engagement, this workshop will bring together clinicians, biologists, engineers and physical scientists, to examine the hurdles that may need to be overcome for effective inter-disciplinary working to achieve MMPathICs objective to get new tests to the clinic or market. Additionally, this workshop will also be an opportunity to inform/ influence the pump-priming flexible fund which is encompassed within the node’s activities, and for which UoM academics and MAHSC clinicians will be able to compete.
You are invited to this Facilitated workshop…
Share your expertise, experiences, interests, successes and failures at this workshop with like-minded individuals?
Time for networking and informal discussion….starting with lunch at 12:00 and finishing at ~17:00 (exact timings TBC) with a coffee/tea break in the afternoon.
Further details on the flexible funding pot (which comprises Workstrand 6 “Innovation and Technologies” of the MMPathIC bid, led by Professor Roy Goodacre) which will pump prime novel interdisciplinary projects will be presented. The event will be an opportunity to influence the criteria around how this funding is allocated.
WHERE: Kanaris Lecture Theatre @ Manchester Museum
WHEN: 14 April (12:00 until ~17:00)
WHAT: Engineering/Physical Sciences Workshop
If you are interested in attending, please register here-
MIMIT (Manchester: Improving Medicine with Innovation and Technology) is internationally recognised for needs-driven, technology innovation that benefits patients.
We initiate, enable and support highly effective collaboration between clinicians, leading academics and researchers as well as industry, to drive innovation on the basis of unmet healthcare need.
Through our extensive network of Site Miners embedded within NHS partner organisations and our Innovation Development PathwayTM, we prime the development of innovative solutions to ‘proof of principle’ stage.